-
Diagnostics World | ADARx Pharmaceuticals will use financing for treatment of a broad range of diseases; A-Alpha Bio plans to use Series A2 funding to accelerate antibody discovery and development for emerging biothreats, including HIV; Cytomos will scale-up market testing of its technology platform for cell analysis; more.
Aug 30, 2023
-
Diagnostics World | The U.S. Food and Drug Administration (FDA) has been making moves signaling its intention to better align the regulatory framework for companion diagnostics (CDx) to what is happening in real-world clinical practice.
Aug 24, 2023
-
Diagnostics World | Public health agencies have grappled with a succession of data problems associated with the COVID-19 pandemic, most notably how to accurately track prevalence rates when people are self-testing in the privacy of their home and don’t necessarily need or want to report the results.
Aug 23, 2023
-
Diagnostics World | Over the next three years, researchers from across five universities in Germany will be using “swarm learning” on retrospective tissue samples to gain insights on the tumor biology of hereditary colorectal cancer (CRC).
Aug 22, 2023
-
Diagnostics World | In a surprising twist, researchers at Sanford Burnham Prebys have found that both age and sex may matter a great deal when it comes to the consequences of many types of cancer.
Aug 16, 2023
-
Diagnostics World | Researchers at the University of Virginia School of Medicine have identified early biomarkers linked to preeclampsia that could help OB/GYNs better understand which of their patients are at risk of developing the potentially deadly pregnancy complication and perhaps help get at why the condition occurs in the first place.
Aug 15, 2023